The best BN, achieved by using the more site-specific musculoskeletal symptom sub-groups, was 76% accurate in predicting the development of PsA in a test set and had an AUC of 0.73 (95% confidence interval (CI) 0.70-0.75).

The presented BN model may be a useful method to identify clusters of symptoms that predict the development of PsA…[Read more]